Roche rejects supply of new AIDS drug

Published: 2008-05-22 06:59:00

Updated: 2008-05-22 06:59:00

Roche, the maker of new AIDS medicine Fuzeon, says it cannot supply the medicine at the insurance price of 25,000 won, which has been recently proposed by the Ministry for Health, Welfare and Family Affairs.

Roche threatens to withdraw its request intended for a government price evaluation in ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK